ID   NAGK_RAT                Reviewed;         343 AA.
AC   P81799; Q32Q91;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   07-APR-2021, entry version 104.
DE   RecName: Full=N-acetyl-D-glucosamine kinase;
DE            Short=N-acetylglucosamine kinase;
DE            EC=2.7.1.59;
DE   AltName: Full=GlcNAc kinase;
GN   Name=Nagk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-13; 69-92; 166-178; 198-207; 221-228; 233-235 AND
RP   308-321, ACETYLATION AT ALA-2, ACTIVITY REGULATION, SUBUNIT, AND FUNCTION.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=9523722; DOI=10.1046/j.1432-1327.1998.2520133.x;
RA   Hinderlich S., Noehring S., Weise C., Franke P., Staesche R., Reutter W.;
RT   "Purification and characterization of N-acetylglucosamine kinase from rat
RT   liver. Comparison with UDP-N-acetylglucosamine 2-epimerase/N-
RT   acetylmannosamine kinase.";
RL   Eur. J. Biochem. 252:133-139(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Converts endogenous N-acetylglucosamine (GlcNAc), a major
CC       component of complex carbohydrates, from lysosomal degradation or
CC       nutritional sources into GlcNAc 6-phosphate. Involved in the N-
CC       glycolylneuraminic acid (Neu5Gc) degradation pathway. Also has ManNAc
CC       kinase activity. {ECO:0000269|PubMed:9523722}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + N-acetyl-D-glucosamine = ADP + H(+) + N-acetyl-D-
CC         glucosamine 6-phosphate; Xref=Rhea:RHEA:17417, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:57513, ChEBI:CHEBI:456216,
CC         ChEBI:CHEBI:506227; EC=2.7.1.59;
CC   -!- ACTIVITY REGULATION: Inhibited by the cysteine modifiers iodoacetamide,
CC       N-ethylmaleimide and 5,5'-dithiobis(2-nitrobenzoic acid).
CC       {ECO:0000269|PubMed:9523722}.
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate degradation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:9523722}.
CC   -!- SIMILARITY: Belongs to the eukaryotic-type N-acetylglucosamine kinase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC107647; AAI07648.1; -; mRNA.
DR   RefSeq; NP_001032857.1; NM_001037768.1.
DR   SMR; P81799; -.
DR   IntAct; P81799; 1.
DR   STRING; 10116.ENSRNOP00000039247; -.
DR   iPTMnet; P81799; -.
DR   PhosphoSitePlus; P81799; -.
DR   jPOST; P81799; -.
DR   PaxDb; P81799; -.
DR   PRIDE; P81799; -.
DR   Ensembl; ENSRNOT00000042875; ENSRNOP00000039247; ENSRNOG00000013911.
DR   GeneID; 297393; -.
DR   KEGG; rno:297393; -.
DR   UCSC; RGD:1305057; rat.
DR   CTD; 55577; -.
DR   RGD; 1305057; Nagk.
DR   eggNOG; KOG1794; Eukaryota.
DR   GeneTree; ENSGT00510000047418; -.
DR   HOGENOM; CLU_016274_0_0_1; -.
DR   InParanoid; P81799; -.
DR   OMA; THVRKAM; -.
DR   OrthoDB; 1572762at2759; -.
DR   PhylomeDB; P81799; -.
DR   TreeFam; TF314158; -.
DR   Reactome; R-RNO-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   SABIO-RK; P81799; -.
DR   UniPathway; UPA00629; -.
DR   PRO; PR:P81799; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000013911; Expressed in brain and 21 other tissues.
DR   Genevisible; P81799; RN.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045127; F:N-acetylglucosamine kinase activity; ISS:UniProtKB.
DR   GO; GO:0009384; F:N-acylmannosamine kinase activity; ISO:RGD.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; ISO:RGD.
DR   GO; GO:0019262; P:N-acetylneuraminate catabolic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR002731; ATPase_BadF.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR039758; NAGK_prok_euk.
DR   PANTHER; PTHR12862; PTHR12862; 1.
DR   Pfam; PF01869; BcrAD_BadFG; 1.
DR   SUPFAM; SSF53067; SSF53067; 2.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Direct protein sequencing; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9523722"
FT   CHAIN           2..343
FT                   /note="N-acetyl-D-glucosamine kinase"
FT                   /id="PRO_0000096698"
FT   REGION          129..130
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   REGION          145..147
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         13
FT                   /note="ATP; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         36
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         107
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         127
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         152
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         214
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         271
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   BINDING         275
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:9523722"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         205
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJ70"
FT   CONFLICT        207
FT                   /note="D -> T (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        226
FT                   /note="Q -> E (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        309
FT                   /note="H -> I (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   343 AA;  37196 MW;  43886E3262D08A0F CRC64;
     MAALYGGVEG GGTRSKVLLL SEDGQILAEA DGLSTNHWLI GTGTCVERIN EMVDRAKRKA
     GVDPLVPLRS LGLSLSGGEQ EDAVRLLMEE LRDRFPYLSE SYFITTDAAG SIATATPDGG
     IVLISGTGSN CRLINPDGSE SGCGGWGHMM GDEGSAYWIA HQAVKIVFDS IDNLEAAPHD
     IGHVKQAMFN YFQVPDRLGI LTHLYRDFDK SKFAGFCQKI AEGAQQGDPL SRFIFRKAGE
     MLGRHVVAVL PEIDPVLFQG ELGLPILCVG SVWKSWELLK EGFLLALTQG REQQAQNSFS
     SFTLMKLRHS SALGGASLGA RHIGHHLPMD YSVNAIAFYS YTF
//
